|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang JS, Lara PN Jr and Pan CX: Progress
in personalizing chemotherapy for bladder cancer. Adv Urol.
2012:3649192012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bambury RM, Power DG and O'Reilly S:
Intratumor heterogeneity and branched evolution. N Engl J Med.
366:2132–2133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Setoyama T, Ling H, Natsugoe S and Calin
GA: Non-coding RNAs for medical practice in oncology. Keio J Med.
60:106–113. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chan B, Manley J, Lee J and Singh SR: The
emerging roles of microRNAs in cancer metabolism. Cancer Lett.
356:301–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Allen KE and Weiss GJ: Resistance may not
be futile: microRNA biomarkers for chemoresistance and potential
therapeutics. Mol Cancer Ther. 9:3126–3136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vinall RL, Ripoll AZ, Wang S, Pan CX and
deVere White RW: MiR-34a chemosensitizes bladder cancer cells to
cisplatin treatment regardless of p53-Rb pathway status. Int J
Cancer. 130:2526–2538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tao J, Lu Q, Wu D, Li P, Xu B, Qing W,
Wang M, Zhang Z and Zhang W: microRNA-21 modulates cell
proliferation and sensitivity to doxorubicin in bladder cancer
cells. Oncol Rep. 25:1721–1729. 2011.PubMed/NCBI
|
|
9
|
Su SF, Chang YW, Andreu-Vieyra C, Fang JY,
Yang Z, Han B, Lee AS and Liang G: miR-30d, miR-181a and
miR-199a-5p cooperatively suppress the endoplasmic reticulum
chaperone and signaling regulator GRP78 in cancer. Oncogene.
32:4694–4701. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv L, Li Y, Deng H, Zhang C, Pu Y, Qian L,
Xiao J, Zhao W, Liu Q, Zhang D, et al: MiR-193a-3p promotes the
multi-chemoresistance of bladder cancer by targeting the HOXC9
gene. Cancer Lett. 357:105–113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deng H, Lv L, Li Y, Zhang C, Meng F, Pu Y,
Xiao J, Qian L, Zhao W, Liu Q, et al: The miR-193a-3p regulated
PSEN1 gene suppresses the multi-chemoresistance of bladder
cancer. Biochim Biophys Acta. 1852:520–528. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deng H, Lv L, Li Y, Zhang C, Meng F, Pu Y,
Xiao J, Qian L, Zhao W, Liu Q, et al: miR-193a-3p regulates the
multi-drug resistance of bladder cancer by targeting the LOXL4 gene
and the oxidative stress pathway. Mol Cancer. 13:2342014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Deng H, Lv L, Zhang C, Qian L, Xiao
J, Zhao W, Liu Q, Zhang D, Wang Y, et al: The miR-193a-3p-regulated
ING5 gene activates the DNA damage response pathway and inhibits
multi-chemoresistance in bladder cancer. Oncotarget. 6:10195–10206.
2015.PubMed/NCBI
|
|
14
|
Gurha P, Abreu-Goodger C, Wang T, RamiRez
MO, Drumond AL, van Dongen S, Chen Y, Bartonicek N, Enright AJ, Lee
B, et al: Targeted deletion of microRNA-22 promotes stress-induced
cardiac dilation and contractile dysfunction. Circulation.
125:2751–2761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li C, Ni J, Liu YX, Wang H, Liang ZQ and
Wang X: Response of MiRNA-22-3p and MiRNA-149-5p to folate
deficiency and the differential regulation of MTHFR
expression in normal and cancerous human hepatocytes. PLoS One.
12:e01680492017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X, Yu H, Lu X, Zhang P, Wang M and Hu
Y: MiR-22 suppresses the proliferation and invasion of gastric
cancer cells by inhibiting CD151. Biochem Biophys Res Commun.
445:175–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song SJ, Poliseno L, Song MS, Ala U,
Webster K, Ng C, Beringer G, Brikbak NJ, Yuan X, Cantley LC, et al:
MicroRNA-antagonism regulates breast cancer stemness and metastasis
via TET-family-dependent chromatin remodeling. Cell. 154:311–324.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song SJ, Ito K, Ala U, Kats L, Webster K,
Sun SM, Jongen-Lavrencic M, Manova-Todorova K, Teruya-Feldstein J,
Avigan DE, et al: The oncogenic microRNA miR-22 targets the TET2
tumor suppressor to promote hematopoietic stem cell self-renewal
and transformation. Cell Stem Cell. 13:87–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Poliseno L, Salmena L, Riccardi L, Fornari
A, Song MS, Hobbs RM, Sportoletti P, Varmeh S, Egia A, Fedele G, et
al: Identification of the miR-106b~25 microRNA cluster as a
proto-oncogenic PTEN-targeting intron that cooperates with
its host gene MCM7 in transformation. Sci Signal.
3:ra292010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo LJ, Zhang LP, Duan CY, Wang B, He NN,
Abulimiti P and Lin Y: The inhibition role of miR-22 in
hepatocellular carcinoma cell migration and invasion via targeting
CD147. Cancer Cell Int. 17:172017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Parrish JK, Sechler M, Winn RA and
Jedlicka P: The histone demethylase KDM3A is a
microRNA-22-regulated tumor promoter in Ewing Sarcoma. Oncogene.
34:257–262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li X, Wang S, Chen Y, Liu G and Yang X:
miR-22 targets the 3′UTR of HMGB1 and inhibits the HMGB1-associated
autophagy in osteosarcoma cells during chemotherapy. Tumour Biol.
35:6021–6028. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bennett G, Sadlier D, Doran PP, Macmathuna
P and Murray DW: A functional and transcriptomic analysis of NET1
bioactivity in gastric cancer. BMC Cancer. 11:502011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He S, Wei YZ, Wang GL, Xu YY, Zhou JM,
Zhang YX and Chen L: Study of RNA interference targeting NET-1
combination with sorafenib for hepatocellular carcinoma therapy in
vitro and in vivo. Gastroenterol Res Pract. 2013:6851502013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahmad HM, Muiwo P, Ramachandran SS, Pandey
P, Gupta YK, Kumar L, Kulshreshtha R and Bhattacharya A: miR-22
regulates expression of oncogenic neuro-epithelial transforming
gene 1, NET1. FEBS J. 281:3904–3919. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaur K, Vig S, Srivastava R, Mishra A,
Singh VP, Srivastava AK and Datta M: Elevated hepatic miR-22-3p
expression impairs gluconeogenesis by silencing the wnt-responsive
transcription factor Tcf7. Diabetes. 64:3659–3669. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gu W, Zhan H, Zhou XY, Yao L, Yan M, Chen
A, Liu J, Ren X, Zhang X, Liu JX and Liu G: MicroRNA-22 regulates
inflammation and angiogenesis via targeting VE-cadherin. FEBS Lett.
591:513–526. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hong Y, Cao H, Wang Q, Ye J, Sui L, Feng
J, Cai X, Song H, Zhang X and Chen X: MiR-22 may suppress
fibrogenesis by targeting TGFbetaR I in cardiac fibroblasts. Cell
Physiol Biochem. 40:1345–1353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen J, Wu FX, Luo HL, Liu JJ, Luo T, Bai
T, Li LQ and Fan XH: Berberine upregulates miR-22-3p to suppress
hepatocellular carcinoma cell proliferation by targeting Sp1. Am J
Transl Res. 8:4932–4941. 2016.PubMed/NCBI
|
|
30
|
Xu D, Guo Y, Liu T, Li S and Sun Y: miR-22
contributes to endosulfan-induced endothelial dysfunction by
targeting SRF in HUVECs. Toxicol Lett. 269:33–40. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Fei B, Wang Q, Song M, Yin Y,
Zhang B, Ni S, Guo W, Bian Z, Quan C, et al: MicroRNA-638 inhibits
cell proliferation, invasion and regulates cell cycle by targeting
tetraspanin 1 in human colorectal carcinoma. Oncotarget.
5:12083–12096. 2014.PubMed/NCBI
|
|
32
|
Lu Z, Luo T, Nie M, Pang T, Zhang X, Shen
X, Ma L, Bi J, Wei G, Fang G and Xue X: TSPAN1 functions as an
oncogene in gastric cancer and is downregulated by miR-573. FEBS
Lett. 589:1988–1994. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Serru V, Dessen P, Boucheix C and
Rubinstein E: Sequence and expression of seven new tetraspans.
Biochim Biophys Acta. 1478:159–163. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Todres E, Nardi JB and Robertson HM: The
tetraspanin superfamily in insects. Insect Mol Biol. 9:581–590.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ye K, Chang S, Li J, Li X, Zhou Y and Wang
Z: A functional and protein-protein interaction analysis of
neuroepithelial cell transforming gene 1 in hepatocellular
carcinoma. Tumour Biol. 35:11219–11227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
zhang J, Wang J, Chen L, Wang G, Qin J, Xu
Y and Li X: Expression and function of NET-1 in human skin squamous
cell carcinoma. Arch Dermatol Res. 306:385–397. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ecimovic P, Murray D, Doran P and Buggy
DJ: Propofol and bupivacaine in breast cancer cell function in
vitro-role of the NET1 gene. Anticancer Res. 34:1321–1331.
2014.PubMed/NCBI
|
|
38
|
Fang L, Zhu J, Ma Y, Hong C, Xiao S and
Jin L: Neuroepithelial transforming gene 1 functions as a potential
prognostic marker for patients with non-small cell lung cancer. Mol
Med Rep. 12:7439–7446. 2015. View Article : Google Scholar : PubMed/NCBI
|
